» Articles » PMID: 36532924

Post-COVID Factor X Deficiency: A Case Report From Pakistan

Overview
Journal Cureus
Date 2022 Dec 19
PMID 36532924
Authors
Affiliations
Soon will be listed here.
Abstract

Acquired Factor X deficiency is a rare hematological disease, characterized by excessive bleeding, with fewer than 50 cases reported in the literature and practically all being associated with amyloidosis. We describe a case of a 38-year-old man with no known family history of hematologic disorders who had symptoms of a mild COVID-19 infection. Upon resolution, he developed excessive bleeding features, including epistaxis and hematuria. It was later found that while the rest of the coagulation factors were within normal limits, Factor X was 7% of the normal value, which reversed about two months after recovery. Our case highlights the significance of the less-expected post-COVID bleeding complications, in contrast to the classically seen thrombotic ones.

Citing Articles

Case report: a case of AL amyloidosis with spontaneous giant retroperitoneal hematoma.

Sheng Y, Zhu H Int J Emerg Med. 2024; 17(1):200.

PMID: 39731001 PMC: 11674221. DOI: 10.1186/s12245-024-00801-3.


Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis.

Rossignon P, Grandjean F, Claessens A, Weynants N Case Rep Hematol. 2023; 2023:5510654.

PMID: 38124779 PMC: 10732816. DOI: 10.1155/2023/5510654.


Acquired Factor X Deficiency without Amyloidosis Presenting with Massive Hematuria: A Case Report and Review of the Literature.

Menakuru S, Dhillon V, Salih A, Beirat A Hematol Rep. 2023; 15(2):312-316.

PMID: 37218824 PMC: 10204373. DOI: 10.3390/hematolrep15020032.

References
1.
Murray N, Guzman E, Del Prado M . Transient acquired factor XII deficiency associated with moderately severe Covid-19 pneumonia. Hematol Transfus Cell Ther. 2021; 43(4):515-517. PMC: 8416650. DOI: 10.1016/j.htct.2021.06.017. View

2.
Ichikawa S, Saito K, Fukuhara N, Tanaka Y, Lee Y, Onodera K . Successful Treatment of Life-threatening Bleeding Caused by Acquired Factor X Deficiency Associated with Respiratory Infection. Intern Med. 2020; 59(10):1303-1308. PMC: 7303456. DOI: 10.2169/internalmedicine.4142-19. View

3.
Shah A, Donovan K, McHugh A, Pandey M, Aaron L, Bradbury C . Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study. Crit Care. 2020; 24(1):561. PMC: 7499016. DOI: 10.1186/s13054-020-03260-3. View

4.
Iba T, Levy J, Levi M, Thachil J . Coagulopathy in COVID-19. J Thromb Haemost. 2020; 18(9):2103-2109. PMC: 7323352. DOI: 10.1111/jth.14975. View

5.
Lee G, Duan-Porter W, Metjian A . Acquired, non-amyloid related factor X deficiency: review of the literature. Haemophilia. 2013; 18(5):655-63. DOI: 10.1111/j.1365-2516.2012.02773.x. View